Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/22962
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chatzikyriakidou, A. | en |
dc.contributor.author | Georgiou, I. | en |
dc.contributor.author | Voulgari, P. V. | en |
dc.contributor.author | Venetsanopoulou, A. I. | en |
dc.contributor.author | Drosos, A. A. | en |
dc.date.accessioned | 2015-11-24T19:29:17Z | - |
dc.date.available | 2015-11-24T19:29:17Z | - |
dc.identifier.issn | 1462-0324 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/22962 | - |
dc.rights | Default Licence | - |
dc.subject | infliximab therapy | en |
dc.subject | ii polymorphism | en |
dc.subject | gene | en |
dc.subject | etanercept | en |
dc.subject | japanese | en |
dc.title | Combined tumour necrosis factor-alpha and tumour necrosis factor receptor genotypes could predict rheumatoid arthritis patients' response to anti-TNF-alpha therapy and explain controversies of studies based on a single polymorphism | en |
heal.type | journalArticle | - |
heal.type.en | Journal article | en |
heal.type.el | Άρθρο Περιοδικού | el |
heal.identifier.primary | 10.1093/rheumatology/kem041 | - |
heal.identifier.secondary | <Go to ISI>://WOS:000247531200029 | - |
heal.identifier.secondary | http://rheumatology.oxfordjournals.org/content/46/6/1034.full.pdf | - |
heal.language | en | - |
heal.access | campus | - |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
heal.publicationDate | 2007 | - |
heal.journalName | Rheumatology | en |
heal.journalType | peer-reviewed | - |
heal.fullTextAvailability | TRUE | - |
Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Chatzikyriakidou-2007-Combined tumour necr.pdf | 86.7 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License